CSL - Cost Of Sales

Stock Price
140.87
Daily Change
-1.31 -0.92%
Monthly
-2.55%
Yearly
-41.74%
Q2 Forecast
135.92

CSL reported $3.87B in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
aTyr Pharma USD 3.34M 18.79M Dec/2025
Cara Therapeutics USD 0 0 Mar/2025
CSL USD 3.87B 2.08B Dec/2025
Curis USD 314K 9.96M Dec/2025
Esperion Therapeutics USD 27.85M 13.43M Dec/2025
Infinity Pharmaceuticals USD 352K 89K Jun/2023
Minerva Neurosciences 386K 31K Jun/2024
Sangamo BioSciences 2.42M 1.11M Jun/2024
TherapeuticsMD USD -11.99M 12.34M Dec/2022